For FormBlends peptide therapy, the useful starting point is not whether the internet is excited about it. It is whether the evidence, safety limits, prescription pathway, and follow-up plan are strong enough to support a real patient decision. A patient I’ll call Greg, a 51-year-old mechanical engineer in Cincinnati,…